Search for a funded project
Inhibition of SARS-Cov2-S - ACE2 interaction AS A THERAPEUTIC TARGET – ACE2-S-Cov
Coronavirus disease 2019 (COVID-19), which is caused by the recently discovered severe acute respiratory [...] respiratory syndrome coronavirus 2 (SARS-CoV-2), has become pandemic, in the absence of an approved drug treatment [...] virus surface spike protein (S), which mediates coronavirus entry into the cell, is an attractive target
Systemic and mucosal immune response variation during SARS-CoV-2 infection and recovery – CoVarImm
Coronavirus disease (COVID-19) is an infectious disease that primarily targets the human respiratory [...] virus denoted ‘Severe Acute Respiratory Syndrome coronavirus 2’ (SARS-CoV-2). The immune response to SARS-CoV-2 [...] Nevertheless, immune responsiveness to this novel coronavirus appears quite variable in humans as indicated
Determinants of SARS-CoV-2 infectivity in a cohort of children and their parents. – PED-COVID_Infect
shedding of Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2), and the duration of viral infectivity [...] prior immunity to SARS-CoV-2 or to seasonal coronaviruses on the duration of SARS-CoV-2 infectivity warrants [...] (ii) pre-existing antibodies towards seasonal coronaviruses; (iii) co-infections with specific respiratory
Role of proinflammatory cytokines, PML nuclear bodies, and the HIRA histone chaperone complex in epigenetic changes associated to SARS-CoV-2 infection – CHROMACoV
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which causes coronavirus disease 2019 (COVID-19)
Genome-wide CRISPR screens for drug target identification and inhibition of SARS-CoV-2 replication – CRISPR-TARGET-CoV
y syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of the current coronavirus disease 2019 [...] global economic crisis. SARS-CoV-2 is the seventh coronavirus identified as capable of infecting humans and
Identification of SARS-CoV-2 RNA ibinding proteins durig viral replication – CoV-2RBP
caused by a novel coronavirus (CoV), the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
NSP3 polyprotein of SARS-CoV2: structural studies and its exploration in drug screening campaign – COVNSP3
alarming emerging infectious disease caused by coronavirus (CoV). The current COVID-19 pandemic, which [...] Wuhan region of China, is caused by a novel coronavirus, SARS-CoV2 which is more infectious than the
Engineering nanobinders to block SARS-CoV-2 entry – SARS2BlockEntry
The novel coronavirus SARS-CoV-2 has recently emerged as a human pathogen in China’s Hubei province, [...] high-titer neutralizing antibodies in others coronaviruses and to fold independently from other spike domains
Pathological findings in critically-ill patients who died from SARS-CoV-2 related acute respiratory distress syndrome – HISTOCOVID
Acute Respiratory Syndrome Coronavirus 2 (SARScov2) is a new coronavirus discovered in December 2019
Development of SARS-CoV-2 vaccines – DC-CoVaC
and easier to produce. Moreover, all Human coronaviruses enter their host cells using the trimeric t [...] transmembrane spike (S) glycoprotein. The coronavirus’ S protein represents a major target for the human